Proactive Investors - Run By Investors For Investors

Medlab's Hall: "Time to offer something new" to challenge reliance on opioids

Medlab Clinical Ltd's (ASX:MDC) Sean Hall tells Proactive that the company is building a cannabis-based drug that is the size of a nanoparticle.

Hall adds that the company is currently intent on marketing the product in around 18 countries, including the EU, the US, Canada, and Australia.

Hall also says that the firm is currently talking to several pharmaceutical firms, two of which are of "significant note".

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
Meet Manolete Partners PLC, Arkle Resources PLC, Royal Road Minerals and Neo Lithium Corp at our event, London , 04 April 2019. Register here »
View full MDC profile View Profile

Medlab Clinical Ltd Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use